$30.78
-1.58 (-4.88%)
Performance
1D
—
1W
-3.69%
1M
-15.11%
3M
-16.22%
6M
+9.42%
1Y
+3.12%
YTD
-9.07%
Open$32.17
Previous Close$32.36
Day High$32.57
Day Low$30.64
52W High$42.68
52W Low$26.81
Volume—
Avg Volume929.4K
Market Cap3.07B
P/E Ratio—
EPS$-1.94
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$36.71
Below
SMA 200
$33.96
Below
RSI (14)
43.9
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
20 analysts
Price Target
+282.3% upside
Current
$30.78
$30.78
Target
$117.67
$117.67
$81.99
$117.67 avg
$158.58
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 223.25M | 137.35M | 384.15M |
| Net Income | -116,057,215 | -64,262,023 | -80,984,777 |
| Profit Margin | -52.0% | -49.4% | -21.1% |
| EBITDA | -159,864,320 | -93,436,141 | -85,173,040 |
| Free Cash Flow | — | — | -100,075,430 |
| Rev Growth | +62.5% | +62.5% | -7.8% |
| Debt/Equity | — | — | 0.22 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $288.24 | -2.24% | 81.4 | 513.86B |
| AMGN | Amgen Inc | $460.28 | -3.80% | 28.5 | 249.09B |
| GILD | Gilead Sciences Inc | $167.57 | -3.96% | — | 212.04B |
| VRTX | Vertex Pharmaceuticals Inc | $542.50 | -1.19% | 30.6 | 134.77B |
| REGN | Regeneron Pharmaceuticals | $902.90 | -2.98% | 19.5 | 84.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.66 | -2.74% | 28.8 | 23.28B |